
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
A new study finds a direct correlation between increasing drug costs and decreasing hospitalization costs.
A new study has found a direct association between rising drug costs and decreases in more expensive hospital care and physician services. Produced by Mark Farrah Associates, a data aggregator and publisher providing health plan market data, the report was published in the America’s Health Insurance Plans’s
To see more Daily News articles,
To go to the Drug Topics homepage,






